Humoral Response of Patients With Autoimmune Rheumatic Disease to BNT162b2 Vaccine: A Retrospective Comparative Study

Objective The effectiveness and safety of SARS-CoV-2 vaccines in patients with autoimmune rheumatic diseases (ARDs) treated with immunomodulators remain uncertain. Therefore, this study aimed to evaluate whether the humoral immune response to the BNT162b2 vaccine differs between patients without and...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaed, Omar, AL Emadi, Samar, Satti, Eman, Muthanna, Bassam, Akkam Veettil, Safna Farsana, Ashour, Hadeel, Chandra, Prem, Alkuwari, Einas A., Coyle, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138718/
https://www.ncbi.nlm.nih.gov/pubmed/35651432
http://dx.doi.org/10.7759/cureus.24585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138718/
https://www.ncbi.nlm.nih.gov/pubmed/35651432
http://dx.doi.org/10.7759/cureus.24585

Ejemplares similares